Skip to main content

Health economic modeling for medical technologies in Europe

Early and comprehensive economic models to determine economic value proposition and inform healthcare decision-makers

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Publication Digest: Private health insurance in the universal public healthcare system: The role of healthcare provision in Finland

07 Jun 2023

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Lavaste investigated the relationship between primary care provision and the uptake of voluntary private health insurance (VPHI) in Finland. By analyzing the data obtained from the national registry and incorporating data on healthcare provider proximity and reimbursement fees, the study reveals that sociodemographic factors (employment, levels of income and education) and patients’ preference are key factors in VPHI uptake and not the (dis)satisfaction with the care provision in public settings. Furthermore, proximity to private (but not public) healthcare providers supports VPHI uptake.

Access the full-text article here.